Barclays’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Barclays’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-245,000	Closed	-$245K	–	7420
2014 Q4	$245K	Hold	245,000	–	–	﹤0.01%	4470
2014 Q3	$490K	Hold	245,000	–	–	﹤0.01%	3969
2014 Q2	$980K	Hold	245,000	–	–	﹤0.01%	3362
2014 Q1	$980K	Sell	245,000 -44,000	-15%	-$226K	﹤0.01%	3254
2013 Q4	$1.16M	Hold	289,000	–	–	﹤0.01%	3238
2013 Q3	$1.45M	Hold	289,000	–	–	﹤0.01%	2944
2013 Q2	$1.25M	Buy	+289,000	New	+$1.31M	﹤0.01%	3084

Barclays's ALXA Position: Q2 2016 in Review

Barclays sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 100 shares.

Barclays first reported a position in ALXA in Q3 2015 and held it in 3 quarters. The position peaked at $3K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

Barclays reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Barclays sold 100 Alexza Pharmaceuticals Inc shares in Q2 2016.
Barclays first reported a position in Alexza Pharmaceuticals Inc in Q3 2015 and held it in 3 quarters.
Barclays's Alexza Pharmaceuticals Inc position peaked at $3K in Q3 2015.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.